[go: up one dir, main page]

NO175885C - Process for the preparation of a salicylic acid-containing agent for the local treatment of skin diseases with peel - Google Patents

Process for the preparation of a salicylic acid-containing agent for the local treatment of skin diseases with peel

Info

Publication number
NO175885C
NO175885C NO891220A NO891220A NO175885C NO 175885 C NO175885 C NO 175885C NO 891220 A NO891220 A NO 891220A NO 891220 A NO891220 A NO 891220A NO 175885 C NO175885 C NO 175885C
Authority
NO
Norway
Prior art keywords
salicylic acid
peel
preparation
skin diseases
local treatment
Prior art date
Application number
NO891220A
Other languages
Norwegian (no)
Other versions
NO891220L (en
NO175885B (en
NO891220D0 (en
Inventor
Konrad Minninger
David Tang
Rainer Oberhagemann
Original Assignee
Konrad Minninger
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Konrad Minninger filed Critical Konrad Minninger
Publication of NO891220L publication Critical patent/NO891220L/en
Publication of NO891220D0 publication Critical patent/NO891220D0/en
Publication of NO175885B publication Critical patent/NO175885B/en
Publication of NO175885C publication Critical patent/NO175885C/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)

Abstract

An agent containing salicylic acid for treating lepidosis in human and veterinary medicine contains 4 to 10 wt. % of salicylic acid, 1 to 7 wt. % of an aliphatic 1,2-diol, and 83 to 95 wt. % of a fatty oil, where the total weight of the agent = 100.
NO891220A 1987-07-25 1989-03-20 Process for the preparation of a salicylic acid-containing agent for the local treatment of skin diseases with peel NO175885C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3724691A DE3724691C2 (en) 1987-07-25 1987-07-25 Pharmaceutical agent for the local therapy of flaking skin diseases
PCT/EP1988/000649 WO1989000853A1 (en) 1987-07-25 1988-07-19 Agent containing salicylic acid for treating lepidosis

Publications (4)

Publication Number Publication Date
NO891220L NO891220L (en) 1989-03-20
NO891220D0 NO891220D0 (en) 1989-03-20
NO175885B NO175885B (en) 1994-09-19
NO175885C true NO175885C (en) 1994-12-28

Family

ID=6332361

Family Applications (1)

Application Number Title Priority Date Filing Date
NO891220A NO175885C (en) 1987-07-25 1989-03-20 Process for the preparation of a salicylic acid-containing agent for the local treatment of skin diseases with peel

Country Status (9)

Country Link
EP (1) EP0325628B1 (en)
JP (1) JPH02500106A (en)
AT (1) ATE69550T1 (en)
AU (1) AU2072088A (en)
DE (2) DE3724691C2 (en)
DK (1) DK173547B1 (en)
FI (1) FI94314C (en)
NO (1) NO175885C (en)
WO (1) WO1989000853A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1001303B (en) * 1989-01-23 1993-07-30 Wolff Chem Pharm Gmbh Method for preparation of a means that contains salicyloxyd against scaling sick
ATE91079T1 (en) * 1989-01-25 1993-07-15 Wolff Chem Pharm Gmbh SALICYLIC ACID AGENT AGAINST SCALPING SKIN DISEASES.
GB9223034D0 (en) * 1992-11-03 1992-12-16 Surtech Int Ltd Method and composition for prevention and/or treatment of dandruff and seborrhoeic dermatitis
SE9403541L (en) * 1994-10-14 1996-04-15 Sven Moberg Antimicrobial composition
US5736580A (en) * 1994-11-14 1998-04-07 Alza Croporation Composition, device, and method for electrotransport agent delivery
US5990179A (en) * 1995-04-28 1999-11-23 Alza Corporation Composition and method of enhancing electrotransport agent delivery
US5985316A (en) * 1995-04-28 1999-11-16 Alza Corporation Composition and method of enhancing electrotransport agent delivery
DE69733968T2 (en) * 1996-09-18 2006-06-01 Applied Genetics Inc. Dermatics NORBORN AND NORBORNANDIOLS FOR THE TREATMENT OF PIGMENTATION DISORDERS, NEURODEGENERATIVE DISEASES OR PROLIFERATIVE SKIN DISEASES
US6623724B2 (en) 1996-09-18 2003-09-23 Applied Genetics Incorporated Dermatics Dermatological compositions and methods
DE10205193A1 (en) * 2002-02-08 2003-08-21 Beiersdorf Ag Cleaning preparations containing diol
DE10341179A1 (en) † 2003-09-06 2005-03-31 Beiersdorf Ag Cosmetic or dermatological preparations containing synergistic combination of alpha- or beta-hydroxyacid and alkanediol, useful for combating acne and/or Propionibacterium acnes infection
WO2013093823A2 (en) 2011-12-20 2013-06-27 Vyome Biosciences Pvt Ltd Topical oil composition for the treatment of fungal infections

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE762726C (en) * 1942-05-02 1952-09-15 Hydrierwerke A G Deutsche Solvent or solubilizer for salicylic acid
JPS57171912A (en) * 1981-04-14 1982-10-22 Sumitomo Chem Co Ltd Cream
FR2585575B1 (en) * 1985-08-01 1989-03-03 Pf Medicament PHARMACEUTICAL COMPOSITIONS WITH KERATOLYTIC ACTIVITY IN GEL FORM COMPRISING HYDROALCOHOLIC SALICYLIC ACID

Also Published As

Publication number Publication date
AU2072088A (en) 1989-03-01
FI891357A (en) 1989-03-22
FI891357A0 (en) 1989-03-22
ATE69550T1 (en) 1991-12-15
DK137589A (en) 1989-05-19
DK173547B1 (en) 2001-02-19
WO1989000853A1 (en) 1989-02-09
FI94314C (en) 1995-08-25
DE3724691C2 (en) 1999-03-18
NO891220L (en) 1989-03-20
FI94314B (en) 1995-05-15
JPH02500106A (en) 1990-01-18
NO175885B (en) 1994-09-19
DE3724691A1 (en) 1989-02-02
NO891220D0 (en) 1989-03-20
EP0325628A1 (en) 1989-08-02
EP0325628B1 (en) 1991-11-21
DK137589D0 (en) 1989-03-21
DE3866344D1 (en) 1992-01-02

Similar Documents

Publication Publication Date Title
ATE75397T1 (en) USE OF VITAMIN E IN THE MANUFACTURE OF PHARMACEUTICALS FOR THE NORMALIZATION OF BLOOD COAGLING IN THERAPY WITH OMEGA-3 TYPE HIGH UNSATURATED FATTY ACIDS.
HK120497A (en) Use of C-22 to C-26 aliphatic alcohols in the treatment of inflammatory and viral skin diseases
SE9401406D0 (en) Pharmaceutical products for curing tumourous diseases and process for preparing same
DE3582439D1 (en) MEDICINE FOR TREATING HEART DISEASES.
HU9300636D0 (en) Medical preparatives, method for producing them and their applications as analgetic and/or febrifuge in human and veterinary medicine
IT1176916B (en) PHARMACEUTICAL OR DIETETIC COMPOSITION WITH HIGH ANTI-THROMBOTIC AND ANTI-ARTERIOSCLEROTIC ACTIVITY
NO175885C (en) Process for the preparation of a salicylic acid-containing agent for the local treatment of skin diseases with peel
ATE120954T1 (en) USE OF ESSENTIAL FATTY ACIDS TO PRODUCE A MEDICINAL PRODUCT FOR THE TREATMENT OF AIDS.
ES478967A1 (en) 3,7-Disubstituted-3-cephem-4-carboxylic acid compounds
DE3762018D1 (en) WASHABLE TOPICAL PREPARATION FOR THERAPY OF PSORIASIS.
DE69005062D1 (en) Fatty acids for the treatment and prevention of skin damage through radiotherapy.
ZA784083B (en) Fatty acid and derivatives thereof,and formulations containing them for use in treatment or prophyllaxis of thrombo-embolic conditions
ES8205190A1 (en) 3,7,11,15-Tetramethyl- 2,4,6,10,14-hexadecapentaenoic Acid
DE3268159D1 (en) Medicaments based on algae, and formulations thereof
NO178457C (en) Process for the Preparation of a Salicylic Acid Preparation for the Treatment of Peel Skin Diseases
SE8800101D0 (en) APPLICATION OF ESSENTIAL FAT ACIDS FOR THE PREPARATION OF A PREPARATION FOR EXAMS TREATMENT
GR890100035A (en) Method for preparation of a means that contains salicyloxyd against scaling sick

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees